NEWS NEW YORK, Nov 08, 2013 (BUSINESS WIRE) -- 2K today

New Post Public Reply Private Reply Replies (0) Message Board
Morgan
NEWS
NEW YORK, Nov 08, 2013 (BUSINESS WIRE) -- 2K today announced that MyNBA2K14, the free companion application to the latest installment of the highest-rated and top-selling NBA video game simulation series*, NBA(R) 2K14, is now available for download on iPad(R), iPhone(R), iPod(R), iPod(R) touch, Android(TM) and Amazon Kindle devices.

Developed in partnership by Visual Concepts and Cat Daddy Games, MyNBA2K14 gives players access to the latest NBA scores, along with two new game modes - MyGame and MyTeam Mobile - enabling access to further the NBA 2K14 console experience at any time and from any location.

MyGame mode lets players earn Virtual Currency (VC) for their console games while on the go - up to 2000 VC every 24 hours - while enjoying direct and real-time access to leaderboards, MyPLAYER profiles, and win/loss records and stats from MyCAREER. In addition, the new MyTeam Mobile allows players to build a card collection of current and former NBA players and battle other MyTeam competitors.

"MyNBA2K14 adds another layer of depth to the NBA 2K14 experience by keeping fans connected to the game wherever they go," said Greg Thomas, president of product development for 2K Sports. "The success of last year's app showed us our fans want an always-on, direct link, and so this year we focused on making the companion app even more robust and feature-rich than before."

Additional features in MyNBA2K14 include:

-- Pick & Win -players earn VC for picking the winners of the next day's real NBA games;

-- VC Draft - provides the chance to earn up to 1500 VC every 24 hours;

-- The "2K Ticker" - streams score data directly from the NBA.

For more information on NBA 2K14, visit https:// www.facebook.com/NBA2K and follow @2K on Twitter.

2K is a wholly owned publishing label of Take-Two Interactive Software, Inc. (NASDAQ: TTWO ).

Take-Two Interactive Software Inc. (TTWO) Stock Research Links

TTWO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading